Home » Drug Information » FDA Approved Drugs » 1997
Medical Areas: Pulmonary/Respiratory Diseases | Infections and Infectious Diseases
View By:YearCompanyConditionsTherapeutic AreasDrug Names
Claritin RediTabs (10 mg loratadine rapidly-disintegrating tablet)
The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Approval Status: Approved January 1997
Treatment Area: seasonal allergy symptoms
Claritin, the first and only nondrowsy allergy product available
in a ready-to-take, rapidly disintegrating tablet, has been
approved for the treatment of seasonal allergy symptoms. The unique
formulation of Claritian RediTabs enables the tablet to
disintegrate almost instantly in the mouth, delivering the proven
efficacy and safety benefits of regular nonsedating Claritin
Claritian RediTabs is indicated for the relief of seasonal
allergy symptoms, including itchy, watery eyes; itchy palate;
sneezing; and chronic idiopathic urticaria (commonly known as
hives). Available by prescription in a once daily, nonsedating
tablet, Claritian RediTabs can be administered to adults and
children as young as 6 years of age, making it an especially
appropriate alternative for children.
In controlled clinical trials using the recommended dose, the
incidence of the most commonly reported adverse events was
comparable to placebo.